rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy

BACKGROUND: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) reduces neutropenia events and is widely used in cancer patients receiving chemotherapy. However, the effects of rhG-CSF on distant organ metastasis (DOM) in non-small-cell lung cancer (NSCLC) patients following postoperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong, Fang, Chen, Chen, Renfang, Yuan, Shangkun, Chen, Lin, Qiu, Xiaotong, Qian, Xiaoying, Zhang, Xinwei, Xiao, Zhehao, Wang, Qian, Fu, Biqi, Song, Xiaoling, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261064/
https://www.ncbi.nlm.nih.gov/pubmed/35799161
http://dx.doi.org/10.1186/s12885-022-09850-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261064/
https://www.ncbi.nlm.nih.gov/pubmed/35799161
http://dx.doi.org/10.1186/s12885-022-09850-4

Ejemplares similares